Acclimatizing with acetazolamide

Journal of Travel Medicine

Volumn 19, Issue 5, 2012, Pages 281-283

  Basnyat, Buddha ^a,b,c  

^a NEPAL INTERNATIONAL CLINIC   (Nepal)

^b OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^c BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; CARBONATE DEHYDRATASE; DEXAMETHASONE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; SPIRONOLACTONE; TADALAFIL;

ALTITUDE; ALTITUDE DISEASE; BRAIN EDEMA; DRUG DOSE REDUCTION; DRUG EFFICACY; ECHOCARDIOGRAPHY; EDITORIAL; GENETIC HETEROGENEITY; HANGOVER; HUMAN; HYPERSENSITIVITY REACTION; HYPOXIA; LUNG ARTERY PRESSURE; LUNG EDEMA; META ANALYSIS; METABOLIC ACIDOSIS; PARESTHESIA; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ACETAZOLAMIDE; ALTITUDE SICKNESS; CARBOLINES; CARBONIC ANHYDRASE INHIBITORS; HUMANS; HYPERTENSION, PULMONARY; MALE; MOUNTAINEERING;

EID: 84865840949     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2012.00646.x     Document Type: Editorial

References (20)

1. Basnyat B, Tabin G,. Altitude illness. In:, Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, eds. Harrison's principles of internal medicine. 18th Ed. New York: McGraw Hill, 2011: e51-56.
2. Basnyat B,. Pilgrimage medicine. BMJ 2002; 324: 745.
3. Ritchie N, Baggott A, Todd A,. Acetazolamide for the prevention of acute mountain sickness-a systematic review and meta-analysis. J Travel Med 2012; 19: 298-307.
4. Leshem E, Caine Y, Rosenberg E, et al. Tadalafil and acetazolamide versus acetazolamide for the prevention of severe high altitude illness. J Travel Med 2012; 19: 308-310.
5. Cain SM, Dunn JE,. Increase of arterial oxygen tension at altitude by carbonic anhydrase inhibition. J Appl Physiol 1965; 20: 882-884.
6. Larsen EB, Roach RC, Schoene RB, et al. Acute mountain sickness and acetazolamide. Clinical efficacy and effect on ventilation. JAMA 1982; 248: 328-332. (Pubitemid 12070767)
7. Dumont L, Mardirosoff C, Tramèr M,. Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review. BMJ 2000; 321: 267-272. (Pubitemid 30487464)
8. Chow T, Browne V, Heilson HL, et al. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial. Arch Intern Med 2005; 165: 296-301. (Pubitemid 40216282)
9. Gertsch JH, Basnyat B, Johnson EW, et al. Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT). BMJ 2004; 328: 797-799. (Pubitemid 38446376)
10. Basnyat B, Gertsch JH, Johnson EW, et al. Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial. High Alt Med Biol 2003; 4: 45-52. (Pubitemid 36511798)
11. Roach RC, Bartsch P, Hackett P, et al. The Lake Louise acute mountain sickness scoring system. In:, Sutton J, Coates G, Huston C, editors. Hypoxia and molecular medicine: Proceedings of the 8th International Hypoxia Symposium, 9-13 February 1993; Lake Louise, Alberta, Canada. Queen City Printers, Burlington, VT; 1993. p. 272-274.
12. Sampson JB, Kobrick JL,. The environmental symptoms questionnaire: revisions and new filed data. Aviat Space Environ Med 1980; 51: 872-877. (Pubitemid 11109159)
13. Basnyat B, Hargrove J, Holck PS, et al. Acetazolamide fails to decrease pulmonary artery pressure at high altitude in partially acclimatized humans. High Alt Med Biol 2008; 9: 209-216.
14. Maggiorini M, Brunner-La Rocca HP, Peth S, et al. Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial. Ann Intern Med 2006; 145: 497-506. (Pubitemid 46780953)
15. Strom BL, Schinnar R, Apter AJ, et al. Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. N Engl J Med 2003; 349: 1628-35. (Pubitemid 37288569)
16. Swenson ER,. Carbonic anhydrase inhibitors and ventilation: a complex interplay of stimulation and suppression. Eur Respir J 1998; 12: 1242-1247. (Pubitemid 29011408)
17. Basnyat B, Holck PS, Pun M, et al. Spironolactone does not prevent acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial by SPACE Trial Group (Spironolactone and Acetazolamide Trial in the Prevention of Acute Mountain Sickness Group). Wilderness Environ Med 2011; 22: 15-22.
18. Jafarian S, Gorouhi F, Salimi S, et al. Sumatriptan for prevention of acute mountain sickness: randomized clinical trial. Ann Neurol 2007; 62: 273-277. (Pubitemid 47525403)
19. Lipman GS, Kannan NC, Holck PS, et al. Ibuprofen prevents altitude illness: a randomized controlled trial for prevention of altitude illness with nonsteroidal anti-inflammatories. Ann Emerg Med 2012; 59: 484-490.
20. Hackett PH, Roach RC, Harrison CL, et al. Respiratory stimulants and sleep periodic breathing at high altitude. Almitrine versus acetazolamide. Am Rev Respir Dis 1987; 135: 896-898.